Workshop on clinical-trial data and transparency
Date:
22/11/2012
Location:
European Medicines Agency, London, UK
The European Medicines Agency has announced that it will proactively publish clinical-trial data and enable access to full data sets by interested parties. A number of practical and policy issues need to be addressed before complex data sets can be made available. This workshop is intended to elicit the views, interests, and concerns from a broad range of institutions, groups and individuals to help the Agency define the modalities of proactive access to clinical-trial data. Registration closed.
-
List item
Agenda - Workshop on access to clinical-trial data and transparency (PDF/72.85 KB)
First published: 20/07/2012
Last updated: 22/11/2012
EMA/406355/2012 -
List item
Speaker biographies - Workshop on clinical-trial data and transparency, 22 November 2012 (PDF/297.39 KB)
First published: 21/11/2012
Last updated: 21/11/2012
EMA/749769/2012 -
List item
Access to clinical-trial data and transparency: Workshop report (PDF/988.77 KB)
First published: 05/12/2012
Last updated: 19/12/2012 -
List item
Presentation - Workshop on access to clinical-trial data (Guido Rasi) (PDF/121.65 KB)
First published: 05/12/2012
Last updated: 05/12/2012 -
List item
Presentation - Workshop on access to clinical-trial data – next steps (Hans-Georg Eichler) (PDF/124.35 KB)
First published: 05/12/2012
Last updated: 05/12/2012 -
List item
Participant list - Workshop on access to clinical-trial data and transparency (PDF/160.97 KB)
First published: 05/12/2012
Last updated: 05/12/2012
EMA/768613/2012